For a cancer patient, a vial of immunotherapy isn’t just medicine it is a lifeline purchased with life savings, loans, and unwavering hope. However, a chilling investigation in April 2026 has pulled back the curtain on a sophisticated “nexus of greed” where high-value oncology drugs are diverted from top-tier hospitals and replaced with lethal or…